Results 271 to 280 of about 590,072 (287)

Biomarkers for immunotherapy of hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2023
Tim F Greten, Augusto Villanueva, Benjamin Ruf   +2 more
exaly  

Hepatocellular carcinoma

Seminars in Surgical Oncology, 1996
openaire   +2 more sources

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

Ca-A Cancer Journal for Clinicians, 2012
Anne Covey
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Molecular therapies and precision medicine for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2018
Josep M Llovet, Daniela Sia, Richard Finn   +2 more
exaly  

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Lancet, The, 2017
Anthony B El-Khoueiry, Bruno Sangro, Thomas Yau   +2 more
exaly  

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Lancet, The, 2018
Matsatoshi Kudo, Richard Finn, Kwang-Hyub Han   +2 more
exaly  

Hepatocellular Carcinoma

New England Journal of Medicine, 2011
openaire   +2 more sources

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Lancet, The, 2002
Josep M Llovet, Carmen Ayuso, Jordi Bruix   +2 more
exaly  

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Cell, 2017
Marco A Marra, Richard A Moore, Karen Mungall   +2 more
exaly